During this period, lysosome-related pathways are activated, resulting in overexpression of SNAP23 and STXBP2, activation of immune effector cells, suppression of the release of immunosuppressive factors, and finally, enhancement of anti-tumor immunity. The gene discussed is SNAP23; the disease is neoplasm.